CN114974530A - Post-diagnosis follow-up method, system and storage medium - Google Patents
Post-diagnosis follow-up method, system and storage medium Download PDFInfo
- Publication number
- CN114974530A CN114974530A CN202210503319.0A CN202210503319A CN114974530A CN 114974530 A CN114974530 A CN 114974530A CN 202210503319 A CN202210503319 A CN 202210503319A CN 114974530 A CN114974530 A CN 114974530A
- Authority
- CN
- China
- Prior art keywords
- follow
- patient
- terminal
- label
- doctor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 57
- 238000003745 diagnosis Methods 0.000 title claims abstract description 31
- 201000010099 disease Diseases 0.000 claims abstract description 73
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 73
- 238000003032 molecular docking Methods 0.000 claims description 23
- 230000002159 abnormal effect Effects 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 16
- 238000004590 computer program Methods 0.000 claims description 6
- 230000002452 interceptive effect Effects 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 4
- 238000013077 scoring method Methods 0.000 claims description 3
- 230000005856 abnormality Effects 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 description 15
- 206010040047 Sepsis Diseases 0.000 description 10
- 206010035664 Pneumonia Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 8
- 206010008118 cerebral infarction Diseases 0.000 description 6
- 208000026106 cerebrovascular disease Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 229940109239 creatinine Drugs 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108010074051 C-Reactive Protein Proteins 0.000 description 3
- 102100032752 C-reactive protein Human genes 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 108010048233 Procalcitonin Proteins 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 208000011140 intestinal infectious disease Diseases 0.000 description 3
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 description 3
- 208000030090 Acute Disease Diseases 0.000 description 2
- 208000033892 Hyperhomocysteinemia Diseases 0.000 description 2
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003225 hyperhomocysteinemia Effects 0.000 description 2
- 201000004193 respiratory failure Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 206010047470 viral myocarditis Diseases 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000002103 Shoulder Fractures Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 208000031294 Upper limb fractures Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Biomedical Technology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
本申请涉及随访系统的技术领域,尤其是涉及一种诊后随访方法、系统及存储介质,其包括:患者根据就诊信息在患者端进行注册以得到相对应的患者账号;平台端获取患者账号并进行存储,平台端根据患者账号所对应的就诊信息将病情标签添加至患者账号,平台端根据就诊信息及病情标签将患者端连接于相对应的医师端并根据预设的随访模板生成相应的随访任务,病情标签表征为患者的患病类型;医师端根据随访任务进行随访,以得到随访结果,并将随访结果发送至平台端。本申请具有提高诊后随访的工作效率的效果。
The present application relates to the technical field of follow-up systems, and in particular, to a post-diagnosis follow-up method, system and storage medium, which include: a patient registers on the patient side according to the visit information to obtain a corresponding patient account; the platform acquires the patient account and Storage, the platform side adds the condition label to the patient account according to the medical treatment information corresponding to the patient account, the platform end connects the patient end to the corresponding physician end according to the medical treatment information and the medical condition label, and generates the corresponding follow-up according to the preset follow-up template. task, the disease label is represented by the disease type of the patient; the physician side conducts follow-up according to the follow-up task to obtain the follow-up result, and sends the follow-up result to the platform side. The present application has the effect of improving the work efficiency of post-diagnosis follow-up.
Description
技术领域technical field
本申请涉及随访系统的技术领域,尤其是涉及一种诊后随访方法、系统及存储介质。The present application relates to the technical field of follow-up systems, and in particular, to a post-diagnosis follow-up method, system and storage medium.
背景技术Background technique
诊后随访是指医院对诊治后的患者通过各种方式,定期跟踪了解患者病情变化,通过发布随访任务,病友患者配合完成,对患者进行专业性康复指导的一种医疗康复观察行为。Post-diagnosis follow-up refers to a kind of medical rehabilitation observation behavior in which the hospital regularly tracks and understands the changes of the patient’s condition through various methods after diagnosis and treatment.
医学上有很多疾病如一些慢性疾病,治疗和恢复会需要一个漫长的过程,由于如今住院平均时间越来越短,越来越多的患者的居家后期康复时间变得越来越长,这就意味着患者的后期护理、病情观察及健康保健等方面的需求越来越高,而对于患者的诊后回访工作,不仅能满足患者在院外的康复治疗需求,也能趋近医院的医疗、服务工作的提高。There are many diseases in medicine, such as some chronic diseases, and the treatment and recovery will take a long process. As the average length of hospital stay is getting shorter and shorter, more and more patients' recovery time at home is getting longer and longer. It means that the needs of patients in post-care, condition observation and health care are getting higher and higher, and the post-diagnosis return visit for patients can not only meet the needs of patients for rehabilitation outside the hospital, but also approach the hospital's medical care and services. work improvement.
如今的患者在出院并院外进行康复时,当需要对自身的康复问题进行咨询的时候,普遍使用网络搜索或去医院进行咨询的方法,而医院方想要了解到患者的身体状况的时候也是使用电话等联系方式与患者取得联系后进行随访工作,医院和患者双方的这种随访方式效率较低,没有办法做到信息的同步性和丰富性。When today's patients are discharged from the hospital and recovering outside the hospital, when they need to consult their own rehabilitation problems, they generally use the method of searching the Internet or going to the hospital for consultation. Follow-up work is carried out after contact with patients by telephone and other contact methods. This follow-up method for both the hospital and the patient is inefficient, and there is no way to achieve synchronization and richness of information.
发明内容SUMMARY OF THE INVENTION
为了提高诊后随访的工作效率,本申请提供一种诊后随访方法、系统及存储介质。In order to improve the work efficiency of post-diagnosis follow-up, the present application provides a post-diagnosis follow-up method, system and storage medium.
第一方面,本申请提供的一种诊后随访方法,采用如下的技术方案:The first aspect, a kind of post-diagnosis follow-up method provided by the application adopts the following technical scheme:
一种诊后随访方法,包括以下步骤:A post-diagnostic follow-up method comprising the following steps:
患者根据就诊信息在患者端进行注册以得到相对应的患者账号;The patient registers on the patient side according to the consultation information to obtain the corresponding patient account;
平台端获取患者账号并进行存储,所述平台端根据所述患者账号所对应的就诊信息将病情标签添加至所述患者账号,所述平台端根据就诊信息及病情标签将所述患者端连接于相对应的医师端并根据预设的随访模板生成相应的随访任务,所述病情标签表征为患者的患病类型;The platform side obtains the patient account and stores it, the platform side adds a condition label to the patient account according to the medical treatment information corresponding to the patient account, and the platform end connects the patient end to the patient account according to the medical treatment information and the medical condition label. The corresponding physician terminal generates a corresponding follow-up task according to a preset follow-up template, and the condition label is characterized as the disease type of the patient;
所述医师端根据所述随访任务进行随访,以得到随访结果,并将随访结果发送至平台端。The doctor terminal performs follow-up according to the follow-up task to obtain follow-up results, and sends the follow-up results to the platform terminal.
在其中的一些实施例中,所述平台端根据所述患者账号所对应的就诊信息将病情标签添加至所述患者账号,包括:In some of these embodiments, the platform adds a condition label to the patient account according to the medical treatment information corresponding to the patient account, including:
根据所述注就诊信息获取患者的就诊病因,并根据就诊病因创建病情标签,并定义为第一病情标签;Obtain the patient's medical treatment etiology according to the described medical treatment information, and create a condition label according to the medical treatment cause, which is defined as the first medical condition label;
将就诊病因输入至历史病因库,判断所述历史病因库内是否存在与就诊病因相关联的高风险并发症信息,所述历史病因库包括各类疾病信息及其相关联的高风险并发疾病信息;Input the cause of medical treatment into the historical etiology database, and determine whether there is high-risk complication information associated with the cause of medical treatment in the historical etiology database, and the historical etiology database includes various disease information and its associated high-risk concurrent disease information ;
若存在,则根据所述就诊病因相关联的高风险并发症信息创建病情标签,并定义为第二病情标签。If there is, a condition label is created according to the high-risk complication information associated with the cause of the visit, and is defined as a second condition label.
在其中的一些实施例中,根据所述就诊病因相关联的高风险并发症信息创建病情标签,并定义为第二病情标签,还包括:In some of these embodiments, a condition label is created according to the high-risk complication information associated with the cause of the visit, and is defined as a second condition label, further comprising:
获取所述就诊病因相关联的高风险并发症信息中的重点检查项数值,将所述就诊信息中的检查项数值与所述重点检查项数值进行比较,以判断是否有至少两个检查项数值出现异常,其中,所述就诊病因相关联的高风险并发症信息中的重点检查项数值表征为患者患上此病症时的极限理论数值;Obtain the value of the key check items in the high-risk complication information associated with the cause of the visit, and compare the value of the check item in the visit information with the value of the key check item to determine whether there are at least two check item values An abnormality occurs, wherein the value of the key check item in the high-risk complication information associated with the cause of the visit is characterized by the limit theoretical value when the patient suffers from the disease;
若就诊信息中的至少两个检查项数值出现异常,那么将此第二病情标签设置为显性标签;If the values of at least two check items in the medical treatment information are abnormal, set the second condition label as a dominant label;
若就诊信息中少于两个检查项数值出现异常,那么将此第二病情标签设置为隐性标签。If the value of less than two check items in the medical consultation information is abnormal, then the second condition label is set as a recessive label.
在其中的一些实施例中,所述平台端根据就诊信息及病情标签将所述患者端连接于相对应的医师端并根据预设的随访模板生成相应的随访任务,包括:In some embodiments, the platform connects the patient to the corresponding physician according to the medical consultation information and the condition label, and generates a corresponding follow-up task according to a preset follow-up template, including:
所述平台端存储有各类疾病相对应预设的随访模板,所述随访模板至少包括患者姓名、就诊信息、患者联系方式、随访日期、随访日志、康复计划、医生姓名、医生联系方式;The platform terminal stores preset follow-up templates corresponding to various diseases, and the follow-up templates include at least patient name, medical visit information, patient contact information, follow-up date, follow-up log, rehabilitation plan, doctor's name, and doctor's contact information;
所述平台端根据病情标签获取相对应的随访模板;The platform terminal obtains a corresponding follow-up template according to the disease label;
所述平台端根据就诊信息自动对随访模板内的信息进行初步填写,并生成相应的随访任务,所述随访任务包括多个随访节点,所述多个随访节点皆对应于一随访时间。The platform automatically preliminarily fills in the information in the follow-up template according to the medical visit information, and generates a corresponding follow-up task, where the follow-up task includes a plurality of follow-up nodes, and the plurality of follow-up nodes all correspond to a follow-up time.
在其中的一些实施例中,所述医师端根据所述随访任务进行随访,以得到随访结果,包括:In some of these embodiments, the physician terminal performs follow-up according to the follow-up task to obtain follow-up results, including:
所述医师端接收随访任务,并根据所述随访任务的随访节点与所述患者端进行连接以进行随访,并根据随访过程对随访任务中的随访节点所对应的随访模板进行更新填写;The physician terminal receives the follow-up task, connects with the patient terminal according to the follow-up node of the follow-up task for follow-up, and updates and fills in the follow-up template corresponding to the follow-up node in the follow-up task according to the follow-up process;
当随访完成后,医师端将更新填写后的随访模板存储至平台端以得到随访结果,患者通过患者端对随访结果进行获取查看。When the follow-up is completed, the physician side stores the updated follow-up template to the platform side to obtain the follow-up results, and the patient obtains and views the follow-up results through the patient side.
在其中的一些实施例中,所述医师端包括就诊医师端、对接医师端和值班医师端,所述平台端根据就诊信息将所述患者端连接于相对应的医师端后,患者使用患者端进行病情查询包括以下步骤:In some of these embodiments, the doctor terminal includes a doctor terminal for a doctor, a docking doctor terminal, and a doctor terminal on duty. After the platform terminal connects the patient terminal to the corresponding doctor terminal according to the consultation information, the patient uses the patient terminal Carrying out a medical inquiry includes the following steps:
所述平台端包括咨询问答库,判断所述患者的病情查询是否包含在所述咨询问答库内;The platform end includes a question-and-answer library, and judges whether the patient's condition query is included in the question-and-answer library;
若包含,则所述对接医师端获得答复权限,并通过咨询问答库获取与病情查询相匹配的答复话术进行答复;If it is included, the docking physician terminal obtains the reply authority, and obtains the reply language matching the condition query through the consultation question-and-answer database to reply;
若不包含,所述对接医师端进行答复后将答复内容及答复权限转送至就诊医师端处进行权限审批,若就诊医师端通过权限审批,则答复内容发送至患者端,若就诊医师端不通过权限审批,则清除所述答复内容且所述答复权限移动至就诊医师端处;If it is not included, the docking doctor terminal sends the reply content and reply authority to the visiting doctor terminal for permission approval after replying. After permission approval, the reply content is cleared and the reply permission is moved to the doctor's side;
若对接医师端的答复时间超过预设时间,则所述答复权限移动至值班医师端处,所述值班医师端判断病情查询是否包含在所述咨询问答库以进行答复。If the answering time of the docking doctor terminal exceeds the preset time, the reply authority is moved to the on-duty doctor's terminal, and the on-duty doctor's terminal judges whether the condition query is included in the consultation question-and-answer database for answering.
在其中的一些实施例中,所述平台端根据所述患者账号所对应的病情标签向所述患者账号内推送宣教内容,具体包括以下步骤:In some of the embodiments, the platform pushes propaganda and education content to the patient account according to the condition label corresponding to the patient account, which specifically includes the following steps:
若所述患者账号只包含第一病情标签,则根据所述第一病情标签推送相对应的第一顺位宣教内容;If the patient account only contains the first disease label, then push the corresponding first-rank propaganda content according to the first disease label;
若所述患者账号包含第一病情标签及第二病情标签,则根据所述第一病情标签推送相对应的第一顺位宣教内容并根据第二病情标签推送相对应的第二顺位宣教内容,其中,第一顺位宣教内容的推送优先级高于第二顺位宣教内容的推送优先级。If the patient account includes a first disease label and a second disease label, push the corresponding first-order propaganda content according to the first disease label and push the corresponding second-order propaganda content according to the second disease label , where the push priority of the first-rank missionary content is higher than that of the second-rank missionary content.
在其中的一些实施例中,还包括评分方法,包括以下步骤:In some of these embodiments, a scoring method is also included, comprising the following steps:
当所述医师端基于所述患者端的操作进行交互更新动作后,所述平台端基于预设的第一得分规则对所述医师端进行智能评分以得到第一得分,所述患者端基于预设的第二得分规则对所述医师端进行人工评分以得到第二得分,所述平台端接收第一得分和第二得分后根据预设的计分规则算出最终得分,并将最终得分关联至医师端的账号上进行显示。After the doctor terminal performs an interactive update action based on the operation of the patient terminal, the platform terminal intelligently scores the doctor terminal based on the preset first scoring rule to obtain the first score, and the patient terminal is based on the preset first scoring rule. According to the second scoring rule, the physician side is manually scored to obtain the second score, and the platform side receives the first score and the second score and calculates the final score according to the preset scoring rule, and associates the final score with the physician displayed on the account of the terminal.
第二方面,本申请提供一种诊后随访系统,采用如下的技术方案:In the second aspect, the application provides a post-diagnosis follow-up system, which adopts the following technical scheme:
一种诊后随访系统,包括患者端、平台端和医师端,其中:A post-diagnosis follow-up system includes a patient end, a platform end and a physician end, wherein:
所述患者端用于供患者根据就诊信息在患者端进行注册以得到相对应的患者账号,患者使用患者端对随访结果进行查看;The patient terminal is used for the patient to register on the patient terminal according to the consultation information to obtain the corresponding patient account, and the patient uses the patient terminal to view the follow-up results;
所述平台端包括存储模块、随访模块、标签模块,所述平台端获取患者账号并根据就诊信息将所述患者端连接于相对应的医师端,所述存储模块对所述患者账号进行存储,所述标签模块用于根据所述患者账号所对应的就诊信息将病情标签添加至所述患者账号,所述随访模块用于根据预设的随访模板生成相应的随访任务;The platform terminal includes a storage module, a follow-up module, and a label module, the platform terminal obtains the patient account and connects the patient terminal to the corresponding doctor terminal according to the medical treatment information, and the storage module stores the patient account number, The labeling module is used to add a condition label to the patient account according to the medical visit information corresponding to the patient account, and the follow-up module is used to generate a corresponding follow-up task according to a preset follow-up template;
所述医师端用于供医师根据所述随访任务对患者端的患者进行随访,以得到随访结果。The doctor terminal is used for the doctor to follow up the patients on the patient terminal according to the follow-up task to obtain follow-up results.
第三方面,本申请提供一种计算机存储介质,采用如下的技术方案:In a third aspect, the application provides a computer storage medium, which adopts the following technical solutions:
一种计算机存储介质,其上存储有计算机程序,所述计算机程序被处理器执行时实现任一项上述的诊后随访方法。A computer storage medium on which a computer program is stored, and when the computer program is executed by a processor, implements any one of the above post-diagnosis follow-up methods.
综上所述,本申请包括以下有益技术效果:To sum up, the present application includes the following beneficial technical effects:
1.患者将根据就诊信息在患者端进行注册,并得到相应的患者账号,并根据就诊信息获得相应的病情标签并进行显示,且根据就诊信息中填写的医生信息连接至相应的医师端,实现患者端和医师端的线上连接,医师端可以通过患者端上显示的病情标签得到相应的随访任务,并通过与患者端连接以进行线上随访,并将随访结果发送至平台端供患者查看,实现快速建立随访任务,并通过线上的方式方便的进行随访工作,无需患者在康复期间反复去医院与医生进行线下随访复诊,提高了随访效率。1. The patient will register on the patient terminal according to the consultation information, and obtain the corresponding patient account, and obtain the corresponding condition label according to the consultation information and display it, and connect to the corresponding doctor terminal according to the doctor information filled in the consultation information to realize Online connection between the patient end and the doctor end, the doctor end can get the corresponding follow-up tasks through the disease label displayed on the patient end, and connect with the patient end to conduct online follow-up, and send the follow-up results to the platform end for patients to view, It realizes the rapid establishment of follow-up tasks, and facilitates follow-up work online, without the need for patients to repeatedly go to the hospital and doctors for offline follow-up and follow-up during the recovery period, which improves the follow-up efficiency.
附图说明Description of drawings
图1是本申请实施例的整体流程示意图;Fig. 1 is the overall flow schematic diagram of the embodiment of the present application;
图2是本申请实施例中设置病情标签的逻辑示意图;Fig. 2 is the logical schematic diagram of setting disease label in the embodiment of the present application;
图3是本申请实施例中进行随访时的流程示意图;Fig. 3 is the schematic flow chart during follow-up visit in the embodiment of the present application;
图4是本申请实施例中进行问询答复时的逻辑示意图;FIG. 4 is a schematic diagram of a logic when inquiring and replying in an embodiment of the present application;
图5是本申请实施例中进行问询答复时判断是否超过答复时间的逻辑示意图;FIG. 5 is a schematic diagram of the logic of judging whether the response time is exceeded when responding to an inquiry in an embodiment of the present application;
图6是本申请实施例中对医师端进行评分时的流程示意图。FIG. 6 is a schematic flowchart of scoring a physician terminal in an embodiment of the present application.
具体实施方式Detailed ways
为更清楚地理解本申请的目的、技术方案和优点,下面结合附图和实施例,对本申请进行了描述和说明。然而,本领域的普通技术人员应该明白,可以在没有这些细节的情况下实施本申请。在一些情形下,为了避免不必要的描述使本申请的各方面变得晦涩难懂,对已经在较高的层次上描述了众所周知的方法、过程、系统、组件和/或电路将不作过多赘述。对于本领域的普通技术人员来说,显然可以对本申请所公开的实施例作出各种改变,并且在不偏离本申请的原则和范围的情况下,本申请中所定义的普遍原则可以适用于其他实施例和应用场景。因此,本申请不限于所示的实施例,而是符合与本申请所要求保护的范围一致的最广泛范围。For a clearer understanding of the purpose, technical solutions and advantages of the present application, the present application is described and illustrated below with reference to the accompanying drawings and embodiments. However, it will be apparent to one of ordinary skill in the art that the present application may be practiced without these details. In some instances, well-known methods, procedures, systems, components and/or circuits have been described at a high level without undue elaboration in order to avoid obscuring aspects of the application with unnecessary description Repeat. It will be apparent to those skilled in the art that various changes can be made in the embodiments disclosed herein, and the general principles defined in this application may be applied to other Examples and application scenarios. Therefore, this application is not limited to the embodiments shown, but is to be accorded the widest scope consistent with the scope of what is claimed herein.
除另作定义外,本申请所涉及的技术术语或者科学术语应具有本申请所属技术领域具备一般技能的人所理解的一般含义。本申请所使用的术语仅出于描述特定实施例的目的,而不旨在于对本申请的限制。如本申请所使用的“一”、“一个”、“一种”、“该”、“这些”等类似的词并不表示数量上的限制,它们可以是单数或者复数。在本申请中所涉及的术语“包括”、“包含”、“具有”及其任何变体,其目的是涵盖不排他的包含;例如,包含一系列步骤或模块(单元)的过程、方法和系统、产品或设备并未限定于列出的步骤或模块(单元),而可包括未列出的步骤或模块(单元),或者可包括这些过程、方法、产品或设备固有的其他步骤或模块(单元)。Unless otherwise defined, the technical or scientific terms involved in this application shall have the general meaning understood by a person with ordinary skills in the technical field to which this application belongs. The terms used in this application are for the purpose of describing particular embodiments only, and are not intended to be limiting of the application. As used in this application, words like "a," "an," "an," "the," "these," and the like do not denote quantitative limitations, and they may be singular or plural. The terms "comprising", "comprising", "having" and any variations thereof referred to in this application are intended to cover non-exclusive inclusion; for example, processes, methods and The system, product or device is not limited to the listed steps or modules (units), but may include unlisted steps or modules (units), or may include other steps or modules inherent to these processes, methods, products or devices (unit).
在本申请中所涉及的“多个”是指两个或两个以上。通常情况下,字符“/”表示前后关联的对象是一种“或”的关系。在本申请中所涉及的术语“第一”、“第二”、“第三”等,只是对相似对象进行区分,并不代表针对对象的特定排序。As used in this application, "plurality" refers to two or more. Normally, the character "/" indicates that the objects associated with each other are an "or" relationship. The terms "first", "second", "third", etc. involved in this application are only for distinguishing similar objects, and do not represent a specific order for the objects.
本申请所涉及的术语“系统”、“引擎”、“单元”、“模块”和/或“块”是一种用于按级别区分不同级别的不同组件、元件、零件、部件、装配件、或功能的一种方法。这些术语可以被其他能够达到相同目的的表达替换。通常,本申请涉及的“模块”、“单元”或“块”是指硬件或者固件中体现的逻辑或软件指令的集合。本申请描述的“模块”、“单元”或“块”可以作为软件和/或硬件实现,并且在作为软件实现的情形下,他们可以被存储在任何类型的非易失性计算机可读存储介质或存储设备中。The terms "system", "engine", "unit", "module" and/or "block" as used in this application are a class of different components, elements, parts, components, assemblies, or a method of functions. These terms can be replaced by other expressions that serve the same purpose. Generally, a "module", "unit" or "block" referred to in this application refers to a collection of logic or software instructions embodied in hardware or firmware. The "modules," "units," or "blocks" described in this application may be implemented as software and/or hardware, and in the case of software implementation, they may be stored in any type of non-volatile computer-readable storage medium or storage device.
在一些实施例中,软件模块/单元/块可以被编译并被链接到可执行程序中。将意识到,软件模块可以是可从其他模块/单元/块或从其自身调用的,和/或可以响应于检测到的事件或中断而被调用。配置为在计算设备上执行的软件模块/单元/块可以设置在计算机可读存储介质上,例如光盘、数字视频盘、闪存驱动器、磁盘、或任何其他有形媒体,或作为数字下载(并且可以最初以压缩或可安装的格式存储,该格式需要在执行之前进行安装、解压或解密)。这样的软件代码可以部分地或全部地存储在正在执行的计算设备的存储设备上,并应用在计算设备的操作之中。软件指令可以被嵌入到固件,例如EPROM中。还将意识到,硬件模块/单元/块可以被包括在连接的逻辑组件中,例如门和触发器,和/或可以被包括在可编程单元中,例如可编程门阵列或处理器。本文描述的模块/单元/块或计算设备功能可以被实现为软件模块/单元/块,还可以以硬件或固件来表示。通常,本文描述的模块/单元/块,它们可以与其他模块/单元/块组合,或者尽管它们是物理组织或存储的,但也可以被划分为子模块/子单元/子块。该描述可以适用于系统、引擎或其一部分。In some embodiments, software modules/units/blocks may be compiled and linked into executable programs. It will be appreciated that a software module may be callable from other modules/units/blocks or from itself, and/or may be called in response to detected events or interrupts. Software modules/units/blocks configured to be executed on a computing device may be provided on a computer-readable storage medium, such as an optical disc, digital video disc, flash drive, magnetic disk, or any other tangible medium, or as a digital download (and may be initially Stored in a compressed or installable format that needs to be installed, decompressed, or decrypted before execution). Such software code may be stored, in part or in whole, on the memory device of the executing computing device and utilized in the operation of the computing device. Software instructions may be embedded in firmware, such as EPROM. It will also be appreciated that hardware modules/units/blocks may be included in connected logic components, such as gates and flip-flops, and/or may be included in programmable units, such as programmable gate arrays or processors. The modules/units/blocks or computing device functions described herein may be implemented as software modules/units/blocks, and may also be represented in hardware or firmware. In general, the modules/units/blocks described herein may be combined with other modules/units/blocks or divided into submodules/subunits/subblocks despite their physical organization or storage. The description may apply to a system, an engine, or a portion thereof.
将理解的是,当单元、引擎、模块或块被称为在另一单元、引擎、模块或块“上”、“连接”或“耦合至”另一单元、引擎、模块或块时,其可以直接在其它单元、引擎、模块或块上,与其连接或耦合或与之通信,或者可以存在中间单元、引擎、模块或块,除非上下文另有明确说明。在本申请中,术语“和/或”可包括任何一个或以上相关所列条目或其组合。It will be understood that when a unit, engine, module or block is referred to as being "on", "connected" or "coupled to" another unit, engine, module or block, it will be understood that Other units, engines, modules or blocks may be directly on, connected or coupled to or in communication with other units, engines, modules or blocks, or there may be intervening units, engines, modules or blocks, unless the context clearly dictates otherwise. In this application, the term "and/or" can include any one or combination of the above associated listed items.
以下结合附图1-6对本申请作进一步详细说明。The present application will be further described in detail below in conjunction with accompanying drawings 1-6.
本申请实施例公开一种诊后随访方法。The embodiment of the present application discloses a post-diagnosis follow-up method.
如图1所示,一种诊后随访方法包括:As shown in Figure 1, a post-diagnostic follow-up method includes:
S100,患者根据就诊信息在患者端进行注册以得到相对应的患者账号。S100, the patient registers on the patient side according to the medical treatment information to obtain a corresponding patient account.
就诊信息包括患者的姓名、性别、联系方式、身份证号码、就诊医师端、挂号信息、检查数值、检查结果、取药信息等信息,其中姓名、性别、联系方式、身份证号码、就诊医师端等信息可以通过手动填写的方式进行填写,而挂号信息、检查数值、检查结果、取药信息等信息可以通过拍摄图片的方式进行上传,当患者进行注册后,会得到患者相对应且具有唯一性的患者账号,此账号用于表征该患者的理疗全过程的记录对象信息。The consultation information includes the patient's name, gender, contact information, ID number, the doctor's terminal, registration information, check values, test results, and information on taking medicines, including name, gender, contact information, ID number, and the doctor's terminal. and other information can be filled in manually, while the registration information, examination value, examination results, medicine information and other information can be uploaded by taking pictures. After the patient registers, the patient will be corresponding and unique. The patient account number, which is used to represent the record object information of the whole process of physiotherapy for the patient.
后续患者想要再次登录此账号的时候,只需要输入自己在注册时预设的登录信息即可,如身份证号码、手机号等。When subsequent patients want to log in to this account again, they only need to enter the login information that they preset during registration, such as ID number, mobile phone number, etc.
S200,平台端获取患者账号并进行存储,平台端通过患者账号所对应的就诊信息将病情标签添加至患者账号,平台端根据就诊信息及病情标签将患者端连接于相对应的医师端并根据预设的随访模板生成相对应的随访任务。S200, the platform side obtains the patient account and stores it, the platform side adds the condition label to the patient account through the medical treatment information corresponding to the patient account, and the platform end connects the patient end to the corresponding physician end according to the medical treatment information and the medical condition label, and The set follow-up template generates corresponding follow-up tasks.
其中,病情标签表征为患者的患病类型。如患者A的就诊信息内显示,患者A的收缩压为170mmHg,舒张压为101mmHg,其大于了正常标准中120-139mmHg的收缩压、80-89mmHg的舒张压,且医生的诊断结果为2级高血压,则生成“2级高血压”的病情标签并将此病情标签添加至患者账号,且需要注意的是,病情标签为显性标签,也就是在用户端和医师端上进行显示时,患者的患者账号旁会对此病情标签进行显示,以方便医生对患者的病情进行快速了解,无需使得医生在面对较多患者时需要反复查看患者上传的就诊信息才能得知患者的病情。Among them, the disease label is characterized by the disease type of the patient. For example, patient A's consultation information shows that patient A's systolic blood pressure is 170mmHg and diastolic blood pressure is 101mmHg, which is greater than the normal standard of 120-139mmHg systolic blood pressure and 80-89mmHg diastolic blood pressure, and the doctor's diagnosis result is grade 2 For high blood pressure, the condition label of "grade 2 hypertension" is generated and added to the patient account. It should be noted that the condition label is an explicit label, that is, when displayed on the user side and the physician side, The condition label will be displayed next to the patient's patient account, so that the doctor can quickly understand the patient's condition, and there is no need for the doctor to repeatedly check the patient's uploaded visit information to know the patient's condition when faced with many patients.
如图2所示,S210,根据就诊信息获取患者的就诊病因,并根据就诊病因创建病情标签,并定义为第一病情标签。As shown in FIG. 2 , in S210 , the cause of the patient's visit is acquired according to the visit information, and a condition label is created according to the cause of the visit, which is defined as the first condition label.
患者在医院进行就诊时,往往会在检查后、手术后等时候得到一份病情检查结果和患病的病因,如在病例上除了检查的数值、手术的日志外还写有患有的疾病类型,如骨折、癌症、冠心病等,这时平台端可以通过患者在患者端上传的就诊信息,如病历图片等,经过图片识别和神经算法得到就诊信息中患病类型,也就是就诊病因,并根据就诊病因创建病情标签,此标签为显性标签,也就是会显示在患者的患者账号上进行显示,并把这个病情标签定义为第一病情标签。When a patient visits a doctor in a hospital, he or she will often get a medical examination result and the cause of the disease after the examination and operation. , such as fractures, cancer, coronary heart disease, etc. At this time, the platform can obtain the disease type in the medical treatment information through image recognition and neural algorithm through the medical treatment information uploaded by the patient on the patient end, such as medical record pictures, and the cause of the medical treatment. A condition label is created according to the cause of the visit. This label is an explicit label, that is, it will be displayed on the patient's patient account, and the condition label is defined as the first condition label.
又例如,在患者A入院前,入院的入院诊断为脑梗塞,在进行治疗后出院时,出院诊断上为脑梗塞与高同型半胱氨酸血症,这可能是患者在住院期间因脑梗塞而出现相关联的疾病的情况,这时根据患者上传就诊信息的时间端为准,若患者在进行检查而没有入院时上传就诊信息,则将“脑梗塞”作为第一病情标签,若患者在出院时再次上传就诊信息,则将第一病情标签更新为“脑梗塞”和“高同型半胱氨酸血症”。需要注意的是,在患者入院进行治疗的过程中,医师端也可以通过更新就诊日志的方式手动对患者的第一病情标签进行更新。For another example, before patient A was admitted to the hospital, the admission diagnosis was cerebral infarction, and when the patient was discharged after treatment, the discharge diagnosis was cerebral infarction and hyperhomocysteinemia, which may be caused by cerebral infarction during hospitalization. In the case of a related disease, the time of uploading the patient's medical information shall prevail. If the patient uploads the medical information during the examination but does not receive the medical information, "cerebral infarction" will be used as the first condition label. If the patient is in the If you upload the medical treatment information again when you are discharged from the hospital, the first condition label will be updated to "cerebral infarction" and "hyperhomocysteinemia". It should be noted that, during the process of the patient being admitted to the hospital for treatment, the physician side can also manually update the patient's first condition label by updating the visit log.
S211,将就诊病因输入至历史病因库,判断历史病因库内是否存在与就诊病因相关联的高风险并发症信息。S211 , input the cause of medical treatment into the historical etiology database, and determine whether there is high-risk complication information associated with the cause of medical treatment in the historical etiology database.
当平台端获取到患者的就诊病因时,平台端可以根据就诊病因推断出患者是否可能存在与就诊病因相关联的高风险并发症。而在平台端内设置有历史病因库,历史病因库内存储有历史诊断过程中所有患者所得的疾病及在治疗就诊过程中出现的高风险并发症情况,并将多种原疾病-并发症的关联关系进行整合连接,得到一个具有若干组关联疾病串构成的疾病提取库,其中关联疾病串可以是一对一或一对多,如高血压作为原疾病时,存在的高风险并发症为中风、脑梗塞、脑血栓、肾小球动脉硬化、肾脏损害、肾功能衰竭,肩膀骨折的高风险并发症为关节炎。When the platform side obtains the cause of the patient's visit, the platform side can infer whether the patient may have high-risk complications associated with the cause of the visit according to the cause of the visit. On the platform side, a historical etiology database is set up. The historical etiology database stores the diseases obtained by all patients in the historical diagnosis process and the high-risk complications that occur during the treatment and consultation process. The association relationship is integrated and connected to obtain a disease extraction library composed of several groups of associated disease strings, where the associated disease strings can be one-to-one or one-to-many. For example, when hypertension is used as the primary disease, the high-risk complication is stroke. , cerebral infarction, cerebral thrombosis, glomerular arteriosclerosis, kidney damage, renal failure, high-risk complication of shoulder fracture is arthritis.
又如轻微感冒因为病状较轻,在大部分时候是不会出现高风险并发症的,可以根据临床的深入去判断轻微感冒的病情是否会加重而再去判断是否存在相应的高风险并发症。Another example is a mild cold, because the symptoms are mild, and high-risk complications will not occur most of the time. It can be judged according to clinical in-depth whether the condition of a mild cold will aggravate and then determine whether there are corresponding high-risk complications.
其中,多个联网医院的历史病因库可以实现共享。Among them, the historical etiology database of multiple networked hospitals can be shared.
S212,若存在,则根据就诊病因相关联的高风险并发症信息创建病情标签,并定义为第二病情标签。S212, if it exists, create a condition label according to the high-risk complication information associated with the cause of the visit, and define it as a second condition label.
若患者治疗肺炎,当患者将就诊信息进行上传后,平台端根据就诊信息得到其就诊病因为肺炎,并将“肺炎”输出至历史病因库内,且历史病因库内存在与“肺炎”相关联得高风险并发症为“脓毒血症”、“病毒性心肌炎”和“呼吸衰竭”,这时平台端将这三个高风险并发症定义为第二病情标签。If the patient is treated for pneumonia, after the patient uploads the medical treatment information, the platform will obtain the cause of pneumonia according to the medical treatment information, and output the "pneumonia" to the historical etiology database, and the historical etiology database is associated with "pneumonia" The high-risk complications are "sepsis", "viral myocarditis" and "respiratory failure". At this time, the platform defines these three high-risk complications as the second condition label.
通过这种方法,在对患者的患病标签进行定义时,可以在对已经确诊的病情进行标记,也同时对患者可能出现的高风险并发症进行标记,使得患者和医生都能提前对已经患上的疾病及可能在未来并发的疾病进行标记预警,并提前做好预防准备。如医生看到患者患上了肺炎,可以在对肺炎进行治疗的同时对可能出现的高风险并发症的身体检查指标进行同步检查,减少突发并发症而无法及时进行救治的可能性。Through this method, when defining the patient's disease label, the already diagnosed disease can be labeled, and the possible high-risk complications of the patient can be labeled at the same time, so that both the patient and the doctor can identify the disease in advance. The diseases on the list and the diseases that may be complicated in the future are marked and early warning, and preventive preparations are made in advance. If the doctor sees that the patient suffers from pneumonia, they can simultaneously check the physical examination indicators of possible high-risk complications while treating the pneumonia, reducing the possibility of sudden complications that cannot be treated in time.
进一步的,因为有一些关于血管、心脏、器官等的疾病会关联有数量较多的高风险并发症出现,而将数量较多的高风险并发症都添加成第二病情标签,不仅要在患者账号上显示过多的病情标签,还会提高患者的忧虑感,且还会对医生的工作添加较多的压力,所以为了能对第二病情标签进行一定的管理分类,故在S212的基础上,还包括以下步骤:Further, because some diseases related to blood vessels, heart, organs, etc. will be associated with a large number of high-risk complications, adding a large number of high-risk complications as a second disease label, not only in patients. Too many condition labels displayed on the account will also increase the patient's anxiety, and will also add more pressure to the doctor's work. Therefore, in order to carry out certain management and classification of the second condition label, on the basis of S212 , which also includes the following steps:
S213,获取就诊病因相关联的高风险并发症信息中的重点检查项数值,将就诊信息中的检查项数值与重点检查项数值进行比较,以判断是否至少有两个检查项数值出现异常。S213: Acquire the value of the key check items in the high-risk complication information associated with the cause of the visit, and compare the value of the check item in the visit information with the value of the key check item to determine whether at least two check item values are abnormal.
就诊病因相关联的重点检查项数值表征为患者患上此病症时的极限理论数值,且当某一项数值高于或低于这个极限理论数值,那么便确定该检查项数值异常,而到底是高于还是低于,则通过临床医学规定进行指定。The value of the key check item associated with the cause of the visit is characterized by the limit theoretical value when the patient suffers from this disease, and when a certain value is higher or lower than this limit theoretical value, then it is determined that the check item value is abnormal, and what is it? Above or below is specified by clinical medical regulations.
如患者A患上了肺炎,其高风险并发症为“脓毒血症”、“病毒性心肌炎”和“呼吸衰竭”,我们以“脓毒血症”为例,脓毒血症重点检查项为白细胞、c反应蛋白、血浆降钙素原、肌酐、凝血功能、血小板、血浆总胆红素、血乳酸等,这些指标是判断是否患上脓毒血症的重点检查项,将就诊信息中的检查项数值和这些重点检查项数值对比,以判断是否有数值出现了异常。For example, patient A suffers from pneumonia, and its high-risk complications are "sepsis", "viral myocarditis" and "respiratory failure". Let's take "sepsis" as an example, and the key examination items for sepsis are White blood cells, c-reactive protein, plasma procalcitonin, creatinine, coagulation function, platelets, plasma total bilirubin, blood lactate, etc. These indicators are the key check items for judging whether to suffer from sepsis. The values of the check items are compared with the values of these key check items to determine whether any values are abnormal.
S214,若就诊信息中的至少两个检查项数值出现异常,那么将第二病情标签设置为显性标签。S214 , if the values of at least two check items in the medical treatment information are abnormal, set the second condition label as a dominant label.
还是以上述的“脓毒血症”为例,当白细胞数量大于12×10的9次方每升或小于4×10的九次方每升时,白细胞的检查项数值为异常、当c反应蛋白超过正常值两倍标准差以上,c反应蛋白的检查项数值为异常、当血浆降钙素原超过正常值两倍标准差以上,血浆降钙素原的检查项数值为异常、当肌酐增高大于44.2微摩尔每升时,肌酐的检查项数值为异常、当活化部分凝血活酶时间aptt大于60秒时,凝血功能的检查项数值为异常、当血小板小于100×10的九次方每升时,血小板的检查项数值为异常、当血乳酸大于1毫摩每升时,血乳酸的检查项数值为异常。Still taking the above-mentioned "sepsis" as an example, when the number of white blood cells is greater than 12 × 10 to the ninth power per liter or less than 4 × 10 to the ninth power per liter, the value of the white blood cell check item is abnormal, and when c reacts. When the protein exceeds two standard deviations of the normal value, the value of the c-reactive protein check item is abnormal. When the plasma procalcitonin exceeds two standard deviations of the normal value, the check item value of plasma procalcitonin is abnormal, and when the creatinine is increased When it is greater than 44.2 micromoles per liter, the value of the check item of creatinine is abnormal; when the activated partial thromboplastin time aptt is greater than 60 seconds, the value of the test item of coagulation function is abnormal; when the platelet is less than 100×10 ninth power per liter When the value of the test item for platelets is abnormal, when the blood lactate is greater than 1 mmol per liter, the value of the test item for blood lactate is abnormal.
那么在将就诊信息中的若干检查项数值与重点检查项数值进行比较后发现,患者A的白细胞、c反应蛋白、肌酐和血小板的数值皆落在重点检查项的极限理论数值外,说明这四项检查项数值是异常的,且出现异常的检查项数值个数大于了两个,那么就认为该患者极大可能在患上肺炎的同时,也患上了脓毒血症这一肺炎的高风险并发症,这时便将“脓毒血症”作为显性的第二病情标签并在患者账号上进行显示,提醒患者和医生注意并发症出现的可能性。Then, after comparing the values of several inspection items in the consultation information with the values of key inspection items, it is found that the values of white blood cells, c-reactive protein, creatinine and platelets of patient A all fall outside the theoretical limit values of key inspection items, indicating that these four The value of the check item is abnormal, and the number of abnormal check item values is greater than two, then it is considered that the patient is most likely to suffer from pneumonia, and also suffer from sepsis, which is a high level of pneumonia. At this time, "sepsis" is used as an explicit second condition label and displayed on the patient account, reminding patients and doctors of the possibility of complications.
如图2所示,以此类推,将患者就诊信息中的检查项数值与可能存在的高风险并发症的重点检查项数值皆进行比较,筛选出较高风险患上的并发症,做为显性标签进行显示。As shown in Figure 2, and so on, compare the values of the check items in the patient's consultation information with the values of the key check items of possible high-risk complications, and screen out the complications with higher risk as the obvious ones. Sex labels are displayed.
S215,若就诊信息中少于两个检查项数值出现异常,那么将第二病情标签设置为隐性标签。S215 , if the values of less than two check items in the medical consultation information are abnormal, set the second condition label as a recessive label.
以上述的“脓毒血症”为例,当把就诊信息中的检查项数值与重点检查项数值进行比较后发现,只有白细胞这一项数据出现了异常,那么便认为患者A极大概率还没有患上脓毒血症这一高风险并发症,那么就将这一个第二病情标签设置为隐性标签,隐性的第二病情标签不会显示在患者账号上,而是进行隐藏处理,减少对患者的心理负担的同时,也可以减少医生的工作压力。当后续就诊信息中的检查项结果进行更新后,如果检查项结果数值变化而导致多于两个检查项结果出现了异常,那么这个隐性的第二病情标签会更新成显性的第二病情标签。Taking the above-mentioned "sepsis" as an example, when comparing the values of the inspection items in the medical treatment information with the values of the key inspection items, it is found that only the data of white blood cells is abnormal, then it is considered that patient A has a high probability of still being diagnosed. If you do not suffer from the high-risk complication of sepsis, then set this second condition label as a hidden label. The hidden second condition label will not be displayed on the patient account, but will be hidden. While reducing the psychological burden on patients, it can also reduce the work pressure of doctors. When the results of the check items in the follow-up visit information are updated, if the value of the check item results changes and the results of more than two check items are abnormal, the recessive second condition label will be updated to an explicit second condition. Label.
通过这种方法,将代表着就诊病因所可能引发的高风险并发症进行分类标签设置,设置显性的第二病情标签可以提醒患者和医生其可能大概率存在患有并发症的可能性,方便患者提前做好准备也方便医生进行后续的跟进治疗,设置隐性的第二病情标签可以对一些目前患病概率较低的并发症进行提前统计,无需医生一直对引发并发症的状况进行考虑,减少了医生的工作压力。Through this method, classification labels are set for high-risk complications that may be caused by the etiology of the visit, and the setting of an explicit second condition label can remind patients and doctors that there is a high probability of the possibility of complications, which is convenient for Preparing patients in advance is also convenient for doctors to carry out follow-up treatment. Setting a hidden second disease label can make early statistics on some complications with a low probability of disease at present, without the need for doctors to always consider the conditions that cause complications. , reducing the work pressure of doctors.
进一步的,为了提高病情标签的提示直观性,平台端可以对病情标签进行颜色区分,区分规则可以通过日常使用积累意见以进行修改,如病情较为严重的第一病情标签使用红色标签,病情较轻的第一病情标签使用绿色标签,第二病情标签同一使用黄色标签,急性疾病使用橙色标签,慢性疾病使用黄色标签等等,因患者可能对一些较为生僻的疾病和并发症不是很了解,所以可能出现较为严重的疾病但是患者并不注意,或较轻的病情患者过分忧虑的情况,所以设置不同颜色的标签将病情标签进行区分,患者可以通过标签的颜色大致了解自身疾病的轻重缓急。Further, in order to improve the intuitiveness of the prompting of the disease label, the platform can distinguish the disease label by color, and the classification rules can be modified through daily use accumulated opinions. For example, the first disease label with more serious disease uses the red label, and the disease is mild The first condition label uses green label, the second condition label uses the same yellow label, acute disease uses orange label, chronic disease uses yellow label, etc. Because patients may not be very familiar with some rare diseases and complications, it is possible If there is a more serious disease but the patient does not pay attention, or the patient with a mild disease is overly worried, labels of different colors are set to distinguish the disease labels, and the patient can roughly understand the priority of their disease through the color of the label.
进一步的,为了减少第二病情标签的误判,当患者端看到自己的患者账号上显示出某一项代表并发症的第二病情标签的时候,经过与医生的沟通后确认不存在第二病情标签上显示的第二病情标签时,患者端可以手动将第二病情标签进行取消显示或隐藏,而后续在出现该并发症症状出现或确定患上此并发症后,可以再手动将第二病情标签进行显示。Further, in order to reduce the misjudgment of the second condition label, when the patient sees a second condition label representing a complication displayed on his patient account, after communicating with the doctor, it is confirmed that there is no second condition label. When the second condition label is displayed on the condition label, the patient side can manually cancel or hide the second condition label, and then after the complication symptoms appear or the complication is confirmed, the second condition label can be manually removed. The condition label is displayed.
患者端为日常使用的移动式联网设备,如手机、平板电脑、笔记本电脑、台式电脑等,也可以是移动式电子手表或医院方定制的患者康复手环等设备,且因为患者最常使用手机或随身的手表或手环对自身的患者账号进行查看,故当以为患者患病后,可能会有多项代表并发症的第二病情标签,这些标签可能无法在手机上一起进行显示,同时,就算可以一起显示也会显得界面过于臃肿,故在另一个实施例中,一个患者端界面中,只在患者账号名旁边显示一个第一病情标签和一个第二病情标签,且这个第二病情标签为平台端经过算法筛选出关联度最高或最高风险的并发症,也可以是患者自己手动调节的,而剩下的第二病情标签则通过数量角标的方式显示在第二病情标签上,如一个患者具有四个第二病情标签,而只对其中一个第二病情标签A进行显示,剩下的三个会在A的右上方显示一个“3”,代表其压缩了三个剩余没有显示的第二病情标签,用户可以通过点击唯一显示的一个第二病情标签以查看自己所有的第二病情标签。后续的医师端同理。The patient side is a mobile networked device that is used daily, such as a mobile phone, tablet computer, laptop computer, desktop computer, etc. It can also be a mobile electronic watch or a patient rehabilitation bracelet customized by the hospital, and because patients most often use mobile phones Or you can check your own patient account with your watch or bracelet. Therefore, when you think that a patient is sick, there may be multiple second disease labels representing complications. These labels may not be displayed together on the mobile phone. At the same time, Even if they can be displayed together, the interface will be too bloated, so in another embodiment, in a patient interface, only one first condition label and one second condition label are displayed next to the patient account name, and the second condition label is displayed. Complications with the highest correlation or highest risk are screened out by an algorithm on the platform, or they can be manually adjusted by the patient, while the remaining second disease labels are displayed on the second disease labels by means of quantitative angle labels, such as one. The patient has four second condition labels, and only one of the second condition labels A is displayed, and the remaining three will display a "3" at the upper right of A, which means that it compresses the three remaining non-displayed first labels. Two condition labels, the user can view all his own second condition labels by clicking on the only displayed second condition label. The same is true for subsequent physicians.
如图3所示,其中,平台端根据就诊信息及病情标签将患者端连接于相应的医师端并根据预设的随访模板生成相应的随访任务,包括以下步骤:As shown in Figure 3, wherein, the platform terminal connects the patient terminal to the corresponding physician terminal according to the consultation information and the condition label, and generates the corresponding follow-up task according to the preset follow-up template, including the following steps:
S220,平台端根据病情标签获取相对应的随访模板。S220, the platform side obtains a corresponding follow-up template according to the condition label.
平台端内预先存储有与各类疾病相对应的随访模板,随访模板上至少包括患者姓名、就诊信息、患者联系方式、随访日期、随访日志、康复计划、医生姓名、医生联系方式等。The platform has pre-stored follow-up templates corresponding to various diseases. The follow-up templates include at least the patient's name, medical information, patient contact information, follow-up date, follow-up log, rehabilitation plan, doctor's name, doctor's contact information, etc.
随访模板在一些细节处,面对不同的疾病有些许的区别,如急性疾病、慢性疾病等根据治疗时间的长短,随访模板中的随访日期、随访日志、康复计划模板等都会有一些不同。There are some details in the follow-up template, which are slightly different for different diseases, such as acute diseases, chronic diseases, etc. According to the length of treatment time, the follow-up date, follow-up log, and rehabilitation plan template in the follow-up template will be somewhat different.
平台端根据病情标签内的内容寻找到相应的随访模板,如患者A的第一患病标签为“糖尿病”,则平台端会在存储的众多预设随访模板内选取糖尿病所对应的随访模板。通过这种方式,方便医师对随访模板中的内容进行填写更新,因为如果所有疾病都共同使用一个随访模板,可能会出现随访过程中发现随访模板与随访进程无法进行匹配的情况出现,而将若干随即模板根据病症进行分类,可以提高对应性和效率。The platform side finds the corresponding follow-up template according to the content in the disease label. For example, if the first disease label of patient A is "diabetes", the platform side will select the follow-up template corresponding to diabetes from among the stored preset follow-up templates. In this way, it is convenient for physicians to fill in and update the content in the follow-up template, because if all diseases use a common follow-up template, it may happen that the follow-up template and the follow-up process cannot be matched during the follow-up process, and some Immediately the templates are classified according to the condition, which can improve correspondence and efficiency.
举个较为极端的例子,若患者A患有癌症,患者B为细菌性肠炎,这时平台端通过患者A的“癌症”的第一病情标签获取相对应的随访模板,同时通过患者B的“细菌性肠炎”的第一病情标签获取相对应的随访模板,而患者A的病情明显严重于患者B,且癌症的治理时间、治疗周期、治疗方法是与细菌性肠炎完全不同的,故患者A的随访模板中,随访周期、随访日期、康复计划等与患者B的随访模板必定是完全不同的。故将不同疾病的随访模板进行分类管理有助于快速地进行随访工作。As an extreme example, if patient A has cancer and patient B has bacterial enteritis, then the platform obtains the corresponding follow-up template through the first condition label of patient A's "cancer", and at the same time obtains the corresponding follow-up template through patient B's "cancer". The corresponding follow-up template can be obtained from the first condition label of bacterial enteritis, and patient A's condition is significantly worse than that of patient B, and the treatment time, treatment cycle, and treatment method of cancer are completely different from those of bacterial enteritis, so patient A In the follow-up template of patient B, the follow-up period, follow-up date, rehabilitation plan, etc. must be completely different from the follow-up template of patient B. Therefore, classifying and managing the follow-up templates of different diseases is helpful for quick follow-up work.
需要注意的是,随访模板的生成只针对于第一病情标签,而不会在自动生成阶段考虑第二病情标签,因为第二病情标签所代表的是并发症,而并发症很可能并没有发生,这时如果根据第二病情标签生成随访模板会提高医生的工作量,而针对于第二病情标签的生成可以等待治疗的深入后,如出现确诊第二病情标签中的并发症时,医生通过医师端手动生成。It should be noted that the generation of the follow-up template is only for the first condition label, and the second condition label is not considered in the automatic generation stage, because the second condition label represents complications, and complications may not occur. At this time, if the follow-up template is generated according to the second condition label, it will increase the workload of the doctor, and the generation of the second condition label can wait for the in-depth treatment. Manually generated on the physician side.
S221,平台端根据就诊信息自动对随访模板内的信息进行初步填写,并生成相应的随访任务。S221, the platform terminal automatically fills in the information in the follow-up template automatically according to the medical visit information, and generates a corresponding follow-up task.
平台端根据就诊信息先自动对随访模板内的基本信息进行填写,如患者的姓名、性别、联系方式、医生姓名、患病种类、检查项数据等,经过填写后生成相应的随访任务,并将随访任务发送至相对应的医师端。当平台端填写数据时便可以根据就诊信息获知患者所关联的医生姓名,便可以根据医生信息将相应的随访任务发送至相对应的医师端。The platform automatically fills in the basic information in the follow-up template according to the consultation information, such as the patient's name, gender, contact information, doctor's name, disease type, inspection item data, etc. The follow-up task is sent to the corresponding physician. When the platform side fills in the data, it can know the doctor's name associated with the patient according to the consultation information, and can send the corresponding follow-up task to the corresponding doctor terminal according to the doctor's information.
随访任务包括多个随访节点,多个随访节点皆对应于一个随访时间。The follow-up task includes multiple follow-up nodes, and each of the multiple follow-up nodes corresponds to a follow-up time.
S300,医师端根据随访任务进行随访,以得到随访结果,并将随访结果发送至平台端。S300, the physician terminal performs follow-up according to the follow-up task to obtain follow-up results, and sends the follow-up results to the platform terminal.
S310,医师端接收随访任务,并根据随访任务的随访节点与患者端进行随访,并根据随访过程对随访任务中的随访节点所对应的随访模板进行更新填写。S310, the physician side receives the follow-up task, and performs follow-up with the patient side according to the follow-up node of the follow-up task, and updates and fills in the follow-up template corresponding to the follow-up node in the follow-up task according to the follow-up process.
S320,当随访完成后,医师端将更新填写后的随访模板存储在平台端以得到随访结果,患者通过患者端对随访结果进行获取查看。S320 , when the follow-up is completed, the physician terminal stores the updated follow-up template on the platform terminal to obtain the follow-up results, and the patient obtains and views the follow-up results through the patient terminal.
如患者A需要进行一周一次的随访,随访时间定为每周周六的晚上5点,那么在这个随访时间内,医生需要通过与患者端进行连接以进行该节点下的随访任务,并根据随访过程将随访模板内的内容进行更新填写,如目前患者的整体状况、用药状况、随访判断、下次到院检查时间等等。当这一节点的随访任务完成后,医师将更新填写好的随访结果发送至平台端,患者端可以进行查看。If patient A needs to follow up once a week, and the follow-up time is set at 5 pm every Saturday, then during this follow-up time, the doctor needs to connect with the patient to perform the follow-up tasks under this node, and according to the follow-up time During the process, the content in the follow-up template is updated and filled, such as the current patient's overall condition, medication status, follow-up judgment, time for the next visit to the hospital, and so on. When the follow-up task of this node is completed, the physician will send the updated follow-up results to the platform, and the patient can view it.
其中,为了对医生对每个随访任务的随访节点进行提醒,可以在每个随访节点所对应的随访时间前一端预设时间设置提醒功能,以响铃等方式通过医师端对医生进行提醒。Among them, in order to remind the doctor of the follow-up node of each follow-up task, a reminder function can be set at a preset time before the follow-up time corresponding to each follow-up node, and the doctor can be reminded by means of a bell or the like.
有时可能出现医生因为工作较多而忘记进行随访任务的情况发生,故患者端对于某一随访节点上的空白随访模板在一端预设时间内具有填写权限,需要注意的是,患者端的填写权限只能用于空白的随访模板,因为非空白的随访模板必定是医师端进行随访后填写的,患者可能会无意的对随访模板上的内容进行修改,这会对后续的治疗产生影响,而用户也只能在医生没有在预定的时间进行随访时,对这一时间点上所对应的节点上的随访模板进行修改,修改的权限可以只限定在随访日志、患者的整体状况、用药情况等内容,使得患者可以在医生无法进行随访时,先将自己的一些状态进行记录,等后续医生通过医师端看到患者更新的随访模板的内容后进行更新修改,以此保证随访任务的连续性。Sometimes it may happen that the doctor forgets to perform the follow-up task due to too much work. Therefore, the patient side has the right to fill in the blank follow-up template on a certain follow-up node within a preset time. It can be used for blank follow-up templates, because non-blank follow-up templates must be filled in by physicians after follow-up visits. Patients may unintentionally modify the contents of the follow-up templates, which will affect subsequent treatment, and users may also Only when the doctor does not follow up at the scheduled time, the follow-up template on the node corresponding to this time point can be modified. The modification authority can only be limited to the follow-up log, the overall condition of the patient, the medication status, etc. This enables patients to record some of their own states when the doctor is unable to follow up, and then update and modify the content of the follow-up template updated by the patient through the doctor's terminal, so as to ensure the continuity of follow-up tasks.
如图4和图5所示,同时,患者在接收随访以外,可能在日常治疗或康复过程中,会出现一些疑问想要询问医生,这时可能患者会不方便去医院的情况,这时患者可能会上网进行查询,而网络上常常会很多错误信息,这些错误信息可能会对患者的康复产生负面作用,这时,如何保证患者端和医师端的线上通讯顺畅性极为重要。As shown in Figure 4 and Figure 5, at the same time, in addition to receiving follow-up visits, the patient may have some questions and want to ask the doctor during the daily treatment or rehabilitation process. At this time, it may be inconvenient for the patient to go to the hospital. It is possible to search online, and there are often a lot of wrong information on the Internet. These wrong information may have a negative effect on the recovery of the patient. At this time, how to ensure the smoothness of online communication between the patient and the doctor is extremely important.
在另一个实施例中,医师端包括就诊医师端、对接医师端和值班医师端。就诊医师端为患者就诊时,负责对患者进行检查、治疗工作的主治医生,对接医师端为与就诊医师相关联的对接医生,可以是同一科室的其他医生或对接医生所管理的医生等等,主要负责在就诊医师工作较忙时与患者进行对接沟通。而值班医生当就诊医生和对接医生皆不在线时负责应对一些突发状况发生的医生,值班医生一般保持24小时在线。In another embodiment, the physician end includes a visiting physician end, a docking physician end, and an on-duty physician end. The visiting physician is the attending doctor who is responsible for the examination and treatment of the patient when the patient visits, and the docking physician is the docking doctor associated with the visiting physician, which can be other doctors in the same department or doctors managed by the docking doctor, etc. Mainly responsible for communicating with patients when the doctor is busy. The doctor on duty is a doctor who is responsible for responding to some emergencies when neither the visiting doctor nor the docking doctor is online. The doctor on duty generally remains online 24 hours a day.
平台端根据就诊信息将患者连接于相对应的医师端后,患者使用患者端进行病情查询包括以下步骤:After the platform terminal connects the patient to the corresponding doctor terminal according to the consultation information, the patient uses the patient terminal to query the condition including the following steps:
S400,判断患者的病情查询是否包含在咨询问答库内。S400, determine whether the patient's condition query is included in the consultation question-and-answer database.
S410,若包含,则对接医师端获得答复权限,并通过咨询问答库获取与病情查询相匹配的答复话术进行答复。S410, if it is included, the docking physician terminal obtains the reply authority, and obtains a reply phrase matching the condition query through the consultation question-and-answer database to reply.
S420,若不包含,则在对接医师进行答复后将答复内容及答复权限转送至就诊医师端进行权限审批,若就诊医师端通过权限审批,则将答复内容发送至患者端,若就诊医师端不通过权限审批,则清除答复内容且答复权限移动至就诊医师端。S420, if not included, after the docking doctor responds, the reply content and the reply authority are forwarded to the visiting physician for permission approval. If the visiting physician passes the permission approval, the reply content is sent to the patient. With permission approval, the reply content will be cleared and the reply permission will be moved to the doctor side.
咨询问答库包含平台端内,咨询问答库内存储有大量的患者常见问题,如某种药剂的用量、自身身体变化所可能带来的问题、何时能预约挂号、主治医生的出诊时间、检查项数值的问题等,并针对于每个问题设定有相对应的答复话术,如A药的使用方法-A药一天食用两次,每次3粒、医生A的出诊时间-医生A的出诊时间为周一到周四的早八点到晚五点等等。The consultation question and answer library includes the platform, and the consultation question and answer library stores a large number of frequently asked questions of patients, such as the dosage of a certain medicine, the problems that may be caused by changes in one's own body, when can an appointment be made, the visiting time of the attending doctor, and the examination. Questions about the value of items, etc., and set up corresponding answering techniques for each question, such as the use of medicine A - take medicine A twice a day, 3 capsules each time, doctor A's visit time - doctor A's Visiting hours are Monday to Thursday from 8:00 am to 5:00 pm and so on.
而当患者通过患者端进行问题询问时,对接医师端的医生看到问题后,搜索咨询问答库内是否存在相对应的答复话术,若包含,则直接使用咨询问答库内的答复话术进行回复。其中,查询方法可以使用常用的关键字提取的方式,如药品名称、医生姓名等,每个关键词可以对应于多个问题,而多个问题对应有多个答复话术,如当医生搜索药品A,会出现若干问题,如药品A的使用方式、药品A的使用禁忌、药品A的价格、药品A的副作用等,医生可以选取相应的答复话术进行回复。When a patient asks a question through the patient terminal, after seeing the question, the doctor connected to the doctor will search whether there is a corresponding answering technique in the Q&A database. . Among them, the query method can use common keyword extraction methods, such as drug name, doctor name, etc. Each keyword can correspond to multiple questions, and multiple questions correspond to multiple answering words, such as when a doctor searches for a drug A, there will be several questions, such as the use of drug A, the contraindication of drug A, the price of drug A, the side effects of drug A, etc. The doctor can choose the corresponding answering technique to reply.
如今在很多领域中都使用平台端自动识别关键词,并通过关键词自动寻找答复话术的方法,但是本申请中,因医疗领域中,对于患者的问题具有较为明确的注意事项,如果通过自动智能回复出现回复错误的情况,使得患者错食的药品,会出现较大的安全事故发生,故在本实施例中,是通过医师手动查询关键词,并手动选择相对应的答复话术的方法,避免出现错误回复导致出现影响患者健康的问题出现。Nowadays, in many fields, the platform automatically recognizes keywords, and automatically finds the method of answering words through keywords. However, in this application, because in the medical field, there are relatively clear precautions for patients' problems. In the case of a wrong reply in the intelligent reply, a large safety accident may occur if the patient ingests the wrong medicine. Therefore, in this embodiment, the doctor manually searches for keywords and manually selects the corresponding reply technique. , to avoid errors that may lead to problems that affect the patient's health.
有一些问题会有一定的针对性,故无法在咨询问答库内找到,这时对接医师可以根据问题进行手动答复。在患者就诊时,主治医生会根据患者的病情制定一套康复计划和随访计划,而在患者询问一些康复内容或随访内容的问题时,对接医师可能会出现不了解康复计划和随访计划而出现错误答复的情况,而为了杜绝此类情况,当对接医师对问题进行手动答复后,需要经过就诊医师端的权限审批。Some questions will be targeted to a certain extent, so they cannot be found in the consultation question and answer database. At this time, the docking doctor can manually answer the question according to the question. When a patient sees a doctor, the attending doctor will formulate a rehabilitation plan and follow-up plan according to the patient's condition. When the patient asks some questions about the content of rehabilitation or follow-up, the docking doctor may not understand the rehabilitation plan and follow-up plan and make mistakes In order to prevent such a situation, when the docking doctor manually answers the question, it needs to be approved by the visiting doctor.
这时,答复内容和答复权限会一同发送至就诊医师端,主治医生接受到后,通过查看答复内容来判断是否通过权限审批,若主治医生认为答复内容没有问题,则通过权限审批,答复内容会直接发送至患者端;若注意医生觉得答复内容与自己设定的康复计划和随访计划有所冲突,则不通过权限审批,这时对接医师端的答复内容会自动删除,并需要就诊医师端对问题进行答复并通过答复权限将答复内容发送至患者端。At this time, the reply content and the reply permission will be sent to the visiting doctor together. After receiving it, the attending doctor will check the reply content to determine whether it has passed the permission approval. Send it directly to the patient terminal; if the doctor feels that the reply content conflicts with the rehabilitation plan and follow-up plan set by him, it will not pass the permission approval, and the reply content from the docking doctor terminal will be automatically deleted, and the doctor needs to answer the question. Make a reply and send the reply content to the patient side through the reply permission.
这么做的好处在于,当对接医师端进行答复后,就诊医师端只需要查看内容是否满足要求,如果满足则不再需要就诊医师进行答复,减少了主治医生的工作量,也同时能保证答复的内容对于患者是起到正确康复效果的,而不满足要求时,主治医生可以自己进行答复,以此在减少工作量的同时保证答复内容的准确性。The advantage of doing this is that when the doctor responds to the docking station, the doctor only needs to check whether the content meets the requirements. If it does, the doctor no longer needs to reply, which reduces the workload of the attending doctor and ensures that the response is accurate. The content has the correct rehabilitation effect for the patient, and when the requirements are not met, the attending doctor can reply by himself, so as to reduce the workload and ensure the accuracy of the reply content.
S430,若对接医师端的答复时间超过预设时间,则答复权限移动至值班医师端处,值班医师端判断病情查询是否半酣在咨询问答库以进行答复。S430 , if the answering time of the docking physician terminal exceeds the preset time, the reply authority is moved to the on-duty physician terminal, and the on-duty physician terminal determines whether the condition inquiry is half-hearted in the consultation question-and-answer database for answering.
有时会出现对接医生因工作需要而无法及时对问题进行回复的情况发生,故设置一个预设时间,可以为3分钟或5分钟,当超过预设时间,答复问题的权限则移动至24小时在线的值班医师端处,值班医生会对问题进行答复。而值班医生在答复时,与对接医生端的答复逻辑是一样的,若问题包含在咨询问答库,则通过库内的答复话术进行答复,若不存在,则手动答复并需要通过就诊医师端的权限。Sometimes it happens that the docking doctor cannot respond to the question in time due to work needs. Therefore, a preset time can be set, which can be 3 minutes or 5 minutes. When the preset time is exceeded, the permission to answer questions will be moved to 24-hour online. The doctor on duty will answer the questions. When the doctor on duty replies, the logic of the answer is the same as that of the docking doctor. If the question is included in the question and answer database, it will be answered through the answering technique in the database. .
以此可以保证患者端与医师端的通讯及时性,使得患者的问题可以尽快得到准确的答复,而无需进行长时间的等待。In this way, the communication timeliness between the patient end and the doctor end can be ensured, so that the patient's question can be answered accurately as soon as possible without a long wait.
平台端还可以根据患者账号所对应的病情标签向患者账号内推送宣教内容,具体包括:The platform side can also push propaganda and education content to the patient account according to the condition label corresponding to the patient account, including:
S500,若患者账号只包含第一病情标签,则根据第一病情标签推送相对应的第一顺位宣教内容。S500, if the patient account only contains the first condition label, push the corresponding first-rank propaganda and education content according to the first condition label.
S510,若患者账号包含第一病情标签及第二病情标签,则根据第一病情标签推送相对应的第一顺位宣教内容,并根据第二病情标签推送相对应的第二顺位宣教内容,其中,第一顺位宣教内容的推送优先级高于第二顺位宣教内容的推送优先级。S510, if the patient account includes a first condition label and a second condition label, push the corresponding first-order propaganda content according to the first disease label, and push the corresponding second-order propaganda content according to the second disease label, Among them, the push priority of the first-rank missionary content is higher than that of the second-rank missionary content.
宣教意为宣传教育,医师端可以上传大量的各类疾病关于治疗、康复、预防等主题的视频、文章、论文等内容至平台端,并根据不同的疾病类型进行分类。Propaganda and education means publicity and education. Doctors can upload a large number of videos, articles, papers, etc. on the topic of treatment, rehabilitation, and prevention of various diseases to the platform, and classify them according to different types of diseases.
平台端再根据患病账号中的病情标签将这些宣教内容进行定向推送。The platform will then push these propaganda and education content in a targeted manner according to the condition label in the sick account.
而在推送时,因第一病情标签为就诊病因,第二病情标签为并发症,故在推送内容时需要设定推送的优先级,因为病人在观看几个宣教内容后会产生疲惫感,若将两种标签所对应的宣教内容一同进行推送,可能会出现患者看了几个第二病情标签所对应的内容后不再看第一病情标签对应的内容,故第一顺位宣教内容的推送优先级高于第二顺位宣教内容的推送优先级。When pushing, because the first condition is labeled as the cause of medical treatment, and the second condition is labeled as complications, it is necessary to set the push priority when pushing the content, because the patient will feel tired after watching several propaganda and education content. If the propaganda content corresponding to the two labels is pushed together, it may happen that the patient will not read the content corresponding to the first disease label after reading the content corresponding to several second disease labels. The priority is higher than the push priority of the second-rank mission content.
如图6所示,其中,为了敦促医师端及时对患者进行随访、答疑等工作,该包括评分方法,包括以下步骤:As shown in Figure 6, in order to urge the physician to follow up the patient and answer questions in a timely manner, the scoring method includes the following steps:
S600,当医师端基于患者端的操作进行交互更新动作后,平台端基于预设的第一得分规则对医师端进行智能评分以得到第一得分,患者端基于预设的第二得分规则对医师端进行人工评分以得到第二得分,平台端接收第一得分和第二得分后根据预设的计分规则算出最终得分,并将最终得分关联至医师端的账号上进行显示S600, after the doctor terminal performs an interactive update action based on the operation of the patient terminal, the platform terminal intelligently scores the doctor terminal based on the preset first scoring rule to obtain the first score, and the patient terminal performs the intelligent scoring on the doctor terminal based on the preset second scoring rule Perform manual scoring to obtain the second score. After receiving the first score and the second score, the platform calculates the final score according to the preset scoring rules, and associates the final score with the doctor's account for display.
进行交互更新动作指的是:患者端与医师端进行随访、医师端对患者端的问题进行答复、医师端对患者端进行的康复计划更新等等。The interactive update action refers to the follow-up between the patient side and the doctor side, the doctor side responding to the patient side's questions, the doctor side updating the rehabilitation plan on the patient side, and so on.
其中,第一得分规则为:根据医师端进行交互的相应时间进行评分,在规定时间内进行解决的,如在规定时间内回复了患者端发出的问题或在规定的时间内进行了随访任务,则给予5分(在此例中,5分为满分),并随着超出规定时间的时间长短进行适量的扣分,如预设在10分钟内进行答复,若超过十分钟,每超过5分钟则扣除1分,以此类推计算出最终得分。Among them, the first scoring rule is: according to the corresponding time when the doctor interacts, and solve it within the specified time, such as replying to the question sent by the patient within the specified time or carrying out the follow-up task within the specified time, 5 points will be given (in this example, 5 points are full points), and appropriate points will be deducted according to the length of time that exceeds the specified time. For example, if the answer is preset within 10 minutes, if it exceeds 10 minutes, every 5 minutes is exceeded. Then deduct 1 point, and so on to calculate the final score.
第二得分规则为:根据使用患者端的患者的整体感受进行评分,如得到答复的时间长短、随访过程中医生的认真程度、对于随访结果的满意程度、对于被推送的宣教内容的满意程度等,可以选择给予0-5分(在本例中,5分为满分)。同时,为了得知患者的意见,可以使患者在评分的同时将扣分理由、意见进行填写,以敦促相应的医师进行改正。The second scoring rule is: score according to the overall feeling of the patients who use the patient terminal, such as the length of time to get a response, the seriousness of the doctor during the follow-up process, the satisfaction with the follow-up results, the satisfaction with the pushed education content, etc. There is an option to give a score of 0-5 (in this case, 5 out of 5). At the same time, in order to know the opinion of the patient, the patient can fill in the reason for the deduction and the opinion while scoring, so as to urge the corresponding physician to make corrections.
当平台端接收到第一得分和第二得分后,可以通过取平均值或加权的方式进行计算。取平均值的方式较为简单,如第一得分为5分,第二得分为4分,这时算出的平均值为4.5分,最后将4.5分做为最终得分,并关联至医师端的账号上进行显示。使用加权的方式是因为平台端的智能评分智能依据交互回复的时间,而患者的评分则是代表患者的真实体验,故患者的评分更大意义上代表着医师端的服务质量,所以可以将第一得分占有30%的权值系数,第二得分占有70%的权值系数,而若第一得分为5分,第二得分为3分,则经过(5*0.3+3*0.7)的计算后得到得数为3.6分。After the platform receives the first score and the second score, it can be calculated by averaging or weighting. The method of taking the average is relatively simple. For example, the first score is 5 points and the second score is 4 points. At this time, the calculated average value is 4.5 points. Finally, 4.5 points are used as the final score, and it is linked to the account of the doctor. show. The weighting method is used because the intelligent score on the platform is based on the time of interactive response, and the patient's score represents the real experience of the patient. Therefore, the patient's score represents the service quality of the doctor in a greater sense, so the first score can be regarded as the first score. It occupies 30% of the weight coefficient, and the second score occupies 70% of the weight coefficient. If the first score is 5 points and the second score is 3 points, then after the calculation of (5*0.3+3*0.7) The score is 3.6 points.
实际应用时,可以根据具体实施过程中出现的问题而对计分规则进行相应的更改。In practical application, the scoring rules can be changed accordingly according to the problems in the specific implementation process.
在另一个实施例中,还公开了一种诊后随访系统,包括患者端、平台端和医师端。In another embodiment, a post-diagnosis follow-up system is also disclosed, including a patient end, a platform end and a physician end.
患者端用于供患者根据就诊信息在患者端进行注册以得到相对应的患者账号,患者使用患者端对随访结果进行查看;The patient terminal is used for the patient to register on the patient terminal according to the consultation information to obtain the corresponding patient account, and the patient uses the patient terminal to view the follow-up results;
平台端包括存储模块、随访模块、标签模块,平台端获取患者账号并根据就诊信息将患者端连接于相对应的医师端,存储模块对患者账号进行存储,标签模块用于根据患者账号所对应的就诊信息将病情标签添加至患者账号,随访模块用于根据预设的随访模板生成相应的随访任务;The platform end includes a storage module, a follow-up module, and a label module. The platform end obtains the patient account and connects the patient end to the corresponding physician end according to the consultation information. The medical treatment information adds the condition label to the patient account, and the follow-up module is used to generate the corresponding follow-up task according to the preset follow-up template;
医师端用于供医师根据随访任务对患者端的患者进行随访,以得到随访结果。The physician side is used for physicians to follow up the patients on the patient side according to the follow-up tasks to obtain follow-up results.
进一步的,平台端还包括历史病因库、咨询问答库、答复模块、权限模块、宣教模块、评分模块等等。Further, the platform side also includes a historical etiology database, a question-and-answer database, a reply module, an authority module, a propaganda module, a scoring module, and so on.
一种诊后随访系统还可以用于预约挂号、患者投诉、满意度调查等功能。A post-diagnosis follow-up system can also be used for functions such as appointment registration, patient complaints, and satisfaction surveys.
另一个实施例公开了一种计算机存储介质,其上存储有计算机程序,计算机程序被处理器执行时实现上述的诊后随访方法。Another embodiment discloses a computer storage medium on which a computer program is stored, and when the computer program is executed by a processor, the above-mentioned post-diagnosis follow-up method is implemented.
以上均为本申请的较佳实施例,并非依此限制本申请的保护范围,故:凡依本申请的结构、形状、原理所做的等效变化,均应涵盖于本申请的保护范围之内。The above are all preferred embodiments of the present application, and are not intended to limit the protection scope of the present application. Therefore: all equivalent changes made according to the structure, shape and principle of the present application should be covered within the scope of the present application. Inside.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210503319.0A CN114974530A (en) | 2022-05-10 | 2022-05-10 | Post-diagnosis follow-up method, system and storage medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210503319.0A CN114974530A (en) | 2022-05-10 | 2022-05-10 | Post-diagnosis follow-up method, system and storage medium |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114974530A true CN114974530A (en) | 2022-08-30 |
Family
ID=82981001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210503319.0A Pending CN114974530A (en) | 2022-05-10 | 2022-05-10 | Post-diagnosis follow-up method, system and storage medium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114974530A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116364233A (en) * | 2023-03-06 | 2023-06-30 | 广东名阳信息科技有限公司 | Prompting method and device after diagnosis |
CN116779190A (en) * | 2023-06-25 | 2023-09-19 | 急尼优医药科技(上海)有限公司 | Medical platform user follow-up management system and method based on Internet of things |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080201174A1 (en) * | 2005-08-29 | 2008-08-21 | Narayanan Ramasubramanian | Personalized medical adherence management system |
CN111739632A (en) * | 2020-06-23 | 2020-10-02 | 苏州工业园区职业技术学院 | A smart healthcare system and its operation method |
CN112837811A (en) * | 2021-03-04 | 2021-05-25 | 复旦大学附属中山医院青浦分院 | Early warning system for drug-induced kidney injury |
CN114023432A (en) * | 2021-11-29 | 2022-02-08 | 青岛大学附属医院 | Parkinson's disease follow-up system |
-
2022
- 2022-05-10 CN CN202210503319.0A patent/CN114974530A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080201174A1 (en) * | 2005-08-29 | 2008-08-21 | Narayanan Ramasubramanian | Personalized medical adherence management system |
CN111739632A (en) * | 2020-06-23 | 2020-10-02 | 苏州工业园区职业技术学院 | A smart healthcare system and its operation method |
CN112837811A (en) * | 2021-03-04 | 2021-05-25 | 复旦大学附属中山医院青浦分院 | Early warning system for drug-induced kidney injury |
CN114023432A (en) * | 2021-11-29 | 2022-02-08 | 青岛大学附属医院 | Parkinson's disease follow-up system |
Non-Patent Citations (1)
Title |
---|
屈新云;李祺;秦菲;周润;沈丹娜: "随访管理信息系统手机医护终端的研发及应用", 中国病案, vol. 17, no. 12, 18 December 2016 (2016-12-18), pages 47 - 49 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116364233A (en) * | 2023-03-06 | 2023-06-30 | 广东名阳信息科技有限公司 | Prompting method and device after diagnosis |
CN116779190A (en) * | 2023-06-25 | 2023-09-19 | 急尼优医药科技(上海)有限公司 | Medical platform user follow-up management system and method based on Internet of things |
CN116779190B (en) * | 2023-06-25 | 2024-02-13 | 急尼优医药科技(上海)有限公司 | Medical platform user follow-up management system and method based on Internet of things |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Samal et al. | Health information technology to improve care for people with multiple chronic conditions | |
US11133111B2 (en) | Methods and systems for an artificial intelligence support network for vibrant constitutional guidance | |
US11392856B2 (en) | Methods and systems for an artificial intelligence support network for behavior modification | |
Gopalan et al. | Decision-making in ICU–a systematic review of factors considered important by ICU clinician decision makers with regard to ICU triage decisions | |
Darkins et al. | Care Coordination/Home Telehealth: the systematic implementation of health informatics, home telehealth, and disease management to support the care of veteran patients with chronic conditions | |
US20210334462A1 (en) | System and Method for Processing Negation Expressions in Natural Language Processing | |
Rollman et al. | The electronic medical record: a randomized trial of its impact on primary care physicians' initial management of major depression | |
US20220384052A1 (en) | Performing mapping operations to perform an intervention | |
US20150106123A1 (en) | Intelligent continuity of care information system and method | |
US11393589B2 (en) | Methods and systems for an artificial intelligence support network for vibrant constitutional guidance | |
King | Illness attributions and the health belief model | |
CN115116569B (en) | Digitizing system for providing digital disease management of cancer | |
WO2021141743A1 (en) | Generating clustered event episode bundles for presentation and action | |
CN112102956A (en) | Method and system for improving compliance of diabetic patient | |
US20240331820A1 (en) | Community based individualized health platforms | |
US10674910B1 (en) | ICU telemedicine system for varied EMR systems | |
CN114974530A (en) | Post-diagnosis follow-up method, system and storage medium | |
CN112466423A (en) | Intelligent chronic disease health management method and system | |
Shahin et al. | The connected intensive care unit patient: exploratory analyses and cohort discovery from a critical care telemedicine database | |
US20230033160A1 (en) | Generating a registry of people using a criteria and performing an action for the registry of people | |
Po et al. | Efficacy of remote health monitoring in reducing hospital readmissions among high-risk postdischarge patients: prospective cohort study | |
Henrich et al. | Digital health needs and preferences during pregnancy and the postpartum period: mixed methods study | |
Lacey et al. | A problem-based nutrition care model that is diagnostic driven and allows for monitoring and managing outcomes | |
Gannon et al. | Rapid expansion of direct-to-consumer telemental health during the COVID-19 pandemic: A case series | |
Zanger | Predicting surgical inpatients' discharges at Massachusetts General Hospital |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |